{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this phase II and pharmacodynamic study, patients with recurrent GBM received RO4929097 in a study of 2 groups."
      },
      "Participants": {
        "score": 1,
        "evidence": "patients with recurrent GBM"
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients with recurrent GBM received RO4929097 in a study of 2 groups."
      },
      "Objective": {
        "score": 1,
        "evidence": "To estimate the 6-mo progression-free survival rate (PFS 6 ) in patients with progressive GBM and to inhibit by 50% the generation of neurospheres in fresh tissue resected from patients treated with RO4929097."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Endpoints included PFS 6 and the inhibition of neurosphere formation in the resected tumor samples."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 47 patients received treatment, 7 of whom had tumor resection."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 47 patients received treatment, 7 of whom had tumor resection."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The PFS 6 was 4%, and the inhibition of neurosphere formation occurred in 1 of 7 patient samples."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  },
  "model": "gpt-4o"
}